ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis

Patients with end-stage renal disease (ESRD) receiving hemodialysis (HD) were found to have a decreased immune response following mRNA COVID-19 immunization. ChAdOx1 nCoV-19 was a promising COVID-19 vaccine that performed well in the general population, but the evidence on immunogenicity in ESRD wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasithsirikul, Wisit, Nopsopon, Tanawin, Phutrakool, Phanupong, Suwanwattana, Pawita, Kantagowit, Piyawat, Pongpirul, Wannarat, Jongkaewwattana, Anan, Pongpirul, Krit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230560/
https://www.ncbi.nlm.nih.gov/pubmed/35746567
http://dx.doi.org/10.3390/vaccines10060959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230560/
https://www.ncbi.nlm.nih.gov/pubmed/35746567
http://dx.doi.org/10.3390/vaccines10060959

Ejemplares similares